PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
02-Nov-2023 Danforth Advisors Expands to Europe with Launch of UK Operations Danforth Advisors
02-Nov-2023 ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results ImmunoGen
02-Nov-2023 MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting MorphoSys AG
02-Nov-2023 The Department of Health - Abu Dhabi launches first of its kind, nationwide Clinical Genomic Medicine and Genetic Counselling Programme The Department of Health – Abu Dhabi (DoH)
02-Nov-2023 Biocair Helps FibroFind Fast-Track Vital Fibrosis Drug Development Biocair
02-Nov-2023 Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma Resolian
02-Nov-2023 Enara Bio, ROME Therapeutics and Nucleome Therapeutics to Host 2nd Annual Dark Genome Symposium Enara Bio
02-Nov-2023 Medicines Optimisation Centricity – Getting It Right Aspire Pharma
02-Nov-2023 UK antibiotic subscription model key to supporting antibiotic investment ABPI
02-Nov-2023 Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023 Biotest AG
02-Nov-2023 Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and earnings in the first nine months of 2023 Drägerwerk AG & Co. KGaA
01-Nov-2023 Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023 Fresenius Medical Care AG & Co. KGaA
01-Nov-2023 NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support NorthX Biologics AB
01-Nov-2023 Aragen setting up a $ 30 million bio-manufacturing site in India Aragen
01-Nov-2023 Prime Global Becomes Prime Prime
01-Nov-2023 CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK CureVac
01-Nov-2023 Evotec SE to announce results for the first nine months 2023 on 08 November 2023 Evotec SE
01-Nov-2023 iOmx Therapeutics attends upcoming scientific and industry conferences iOmx Therapeutics AG
01-Nov-2023 Spexis Announces Changes to the Executive Committee Spexis AG
31-Oct-2023 LEO Pharma announces positive outcome of DELTA 3 open-label extension trial of delgocitinib cream in the treatment of adults with moderate to severe chronic hand eczema (CHE) LEO Pharma